Phenotypic and genotypic characterization of VanA Enterococcus isolated during the first nosocomial outbreak in Brazil

Microbial Drug Resistance

Volumn 9, Issue 3, 2003, Pages 283-291

  Zanella, Rosemeire C ^a   Brandileone, Maria Cristina C ^a   Bokermann, Sérgio ^a   Almeida, Samanta C G ^a   Valdetaro, Fábio ^b   Vitório, Fábio ^b   Moreira de Fátima, A Maria ^b   Villins, Margarete ^b   Salomão, Reinaldo ^b   Pignatari, Antonio Carlos C ^c  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b HOSPITAL SANTA MARCELINA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CIPROFLOXACIN; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRAZIL; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EPIDEMIC; GENOTYPE; HOSPITAL INFECTION; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SPECIES;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 0042355373     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/107662903322286490     Document Type: Article

References (32)

1. Bates, J., J. Jordens, and D.T. Griffith. 1994. Farm animals as a putative reservoir for vancomycin resistant enterococcal infections in man. Antimicrob. Agents Chemother. 34:507-516.
2. Biavasco, F., A. Miele, C. Vignaroli, E. Manso, R. Lupidi, and P.E. Varaldo. 1996. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. Microb. Drug Resist. 2:231-237.
3. Boyce, J.M. 1997. Vancomycin-resistant Enterococcus. Detection, epidemiology and control measures. Infect. Dis. Clinics N. Am. 11:367-384.
4. Boyle, J.F., S.A. Soumakis, A. Rendo, J.A. Herrington, D.G. Gianarkis, B.E. Thurberg, and B.G. Painter. 1993. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J. Clin. Microbiol. 31:1280-1285.
5. Centers for Disease Control and Prevention: Nosocomial Enterococci Resistant to Vancomycin-United States, 1989-1993. 1993. MMWR Morbid Mortal Wekly Rep. 42:597-599.
6. Darini, A.L.C., R.C. Zanella, M.C.C. Brandileone, A.C.C. Pignatari, and N. Woodford. 2000. Molecular analysis of VanA elements from strains of Enterococcus faecium and Enterococcus faecalis isolated during the first outbreak of glycopeptide-resistant enterococci (GRE) in Brazil. In: Abstracts. Ist International ASM Conference on Enterococci: Pathogenesis, Biology and Antibiotic resistance, Banff, Canada, vol. 71, pp. 49-50.
7. De Lencastre, H., A.E. Brown, M. Chung, D. Armstrong, and A. Tomasz. 1999. Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcusfaecium in the Pediatric Oncology Unit of a New York City Hospital. Microb. Drug Resist. 5:113-129.
8. Dutka-Malen, S., S. Evers, and P. Couvarlin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27. (Erratum 33:1434).
9. Eliopoulos, G.M. 1997. Vancomycin-resistant enterococci. Antimicrob. Drug Resist. 11:851-865.
10. Facklam, R.R., D.A. Sahm, and L.M. Teixeira. 1999. Enterococcus. In P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, and R.H. Yolken (eds.), Manual of clinical microbiology, 7th ed. American Society for Microbiology, Washington, pp. 297-305.
11. Free, L., and D.F. Sahm. 1996. Detection of enterococcal vancomycin resistance by multiplex PCR. In D.H. Persing (ed.), Diagnostic molecular microbiology: principles and applications (supplement). ASM Press, Washington, DC.
12. Frieden, T.R., S.S. Munsiff, D.E. Low, B.M. Willey, G. Williams, Y. Faur, W. Eisner, S. Warren, and B. Kreiswirth. 1993. Emergence of vancomycin-resistant enterococci in New York City. Lancet 342:76-79.
13. Gordon, S., J.M. Swenson, B.C. Hill, N.E. Pigott, R.R. Facklam, R.C. Cooksey, C. Thornsberry, Enterococcal Study Group, W.R. Jarvis, and F.C. Tenover. 1992. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J. Clin. Microbiol. 30:2373-2378.
14. Ieven, M., E. Vercauteren, P. Descheemaeker, F. Van Laer, and H. Goossens. 1999. Comparison of direct and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients. J. Clin. Microbiol. 37:1436-1440.
15. Klare, I., H. Heier, H. Claus, R. Reissbrodt, and W. Witte. 1995. VanA mediated high level glycopeptide resistance in Enterococcus faecium from animals husbandry. FEMS Microbiol. Lett. 125:165-172.
16. Leclerq, R., E. Derlot, M. Weber, J. Duval, and P. Couvarlin. 1988. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
17. Mato, R., H. Lencastre, R.B. Roberts, and A. Tomasz. 1996. Multiplicity of genetic backgrounds among vancomycin-resistant Enterococcus faecium isolates recovered from an outbreak in a New York City Hospital. Microb. Drug Resist. 2:309-317.
18. Matzke, G.R., R.W. Mcgray, C.E. Halstenson, and W.F. Keane. 1984. Pharmacokinetics of vancomycin in patients with various degrees of renal infections. Anfimicrob. Agents Chemother. 25:433-437.
19. McDonald, L.C., M.J. Kuerhnert, F.C. Tenover, and R.W. Jarvis. 1997. Vancomycin-resistant enterococci outside the healthcare setting: prevalence, sources, and public health implications. Emerg. Infect. Dis. 3:311-317.
20. Moellering, R.C., Jr. 1992. Emergence of Enterococcus as a significant pathogen. Clin. Infect. Dis. 14:1173-1178.
21. Murray, B.E. 1998. Diversity among multidrug-resistant enterococci. Emerg. Infect. Dis. 4:37-47.
22. Murray, B.E. 1990. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3:46-65.
23. National Committee for Clinical Laboratory Standards (NCCLS). 1998. Methods of dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, PA.
24. O'Callaghan, C.H., A. Morris, S.M. Kirby, and A.H. Shingler. 1972. Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:282-288.
25. Rosenberg, J., F.C. Tenover, J. Wong, W. Jarvis, and D.J. Vugia. 1997. Are clinical laboratories in California accurately reporting vancomycin-resistant enterococci? J. Clin. Microbiol. 35:2526-2530.
26. Ruoff, K.L., L. Maza, M.J. Murtagh, J.D. Spargo, and M.J. Ferraro. 1990. Species identities of Enterococci isolated from clinical specimens. J. Clin. Microbiol. 28:435-437.
27. Tenover, F.C., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
28. Uttley, A.H.C., C.H. Collins, J. Naido, and R.C. George. 1998. Vancomycin-resistant enterococci. Lancet i:57-58.
29. Weinstein, J.W., M. Roe, M. Towns, L. Sanders, J.J. Thorpe, R. Corey, and D.J. Sexton. 1996. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a University Hospital. Infect. Control. Hosp. Epidemiol. 17:36-41.
30. Wells, V.D., E.S. Wong, B.E. Murray, P.E. Coundran, D.S. Williams, and S.M. Markowitz. 1992. Infections due to beta-lactamase-producing high level gentamycin-resistant Enterococcus faecalis. Ann. Intern. Med. 116:285-292.
31. Witte, W., and I. Klare. 1995. Glycopeptide-resistant Enterococcus faecium outside hospitals: a commentary. Microb. Drug Resist. 1:259-263.
32. Zanella, R.C., F. Valdetaro, M. Lovgren, G.J. Tyrrel, S. Bokermann, S.C.G. Almeida, V.S. Vieira, and M.C.C. Brandileone. 1999. First confirmed case of a vancomycin-resistant Enterococcus faecium with VanA phenotype from Brazil: isolation from a meningitis case in São Paulo. Microb. Drug Resist. 5:159-161.